Skip to main content
Article thumbnail
Location of Repository

Tumor-Immune Interaction, Surgical Treatment, and Cancer Recurrence in a Mathematical Model of Melanoma

By Steffen Eikenberry, Craig Thalhauser and Yang Kuang

Abstract

Malignant melanoma is a cancer of the skin arising in the melanocytes. We present a mathematical model of melanoma invasion into healthy tissue with an immune response. We use this model as a framework with which to investigate primary tumor invasion and treatment by surgical excision. We observe that the presence of immune cells can destroy tumors, hold them to minimal expansion, or, through the production of angiogenic factors, induce tumorigenic expansion. We also find that the tumor–immune system dynamic is critically important in determining the likelihood and extent of tumor regrowth following resection. We find that small metastatic lesions distal to the primary tumor mass can be held to a minimal size via the immune interaction with the larger primary tumor. Numerical experiments further suggest that metastatic disease is optimally suppressed by immune activation when the primary tumor is moderately, rather than minimally, metastatic. Furthermore, satellite lesions can become aggressively tumorigenic upon removal of the primary tumor and its associated immune tissue. This can lead to recurrence where total cancer mass increases more quickly than in primary tumor invasion, representing a clinically more dangerous disease state. These results are in line with clinical case studies involving resection of a primary melanoma followed by recurrence in local metastases

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2667258
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). A mathematical model for the regulation of tumor dormancy based on enzyme kinetics.
    2. (1997). Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.
    3. (2003). Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications.
    4. (1999). Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization.
    5. (2002). Dermatological aspects of Angiogenesis.
    6. (2007). Endothelial Cell Migration During Angiogenesis.
    7. (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance.
    8. (2006). Induction of secreted matrix metalloproteinas-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.
    9. (2003). Insights into the mechanisms of lymph node metastasis.
    10. (2004). Local Melanoma Recurrence: A Clarification of Terminology.
    11. (2001). Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells.
    12. (2007). Melanoma biology and new targeted therapy.
    13. (2007). The Biology of Cancer Garland Science:
    14. (2000). The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF upregulation in the angiogenesis of human melanoma xenografts.
    15. (2007). The Matrix Revolutions: Matrix Metalloproteinase, Vasculogenesis, and Ischemic Tissue Repair.
    16. (2003). The vascular phenotype of melanoma metastasis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.